Search | IOVS | ARVO Journals

View

Showing 1 – 17 of 17

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2022

Safety and effectiveness of the fluocinolone acetonide intravitreal implant (ILUVIEN): Final study results from the European IRISS registry study

Ramin Khoramnia; Tunde Peto; Simon R Taylor; Joao Paulo Castro de Sousa; Lauren Hill; Clare Bailey; Usha Chakravarthy

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):2182 – F0245. doi:

ARVO Annual Meeting Abstract June 2021

Comparison of Vascular Endothelial Growth Factors (VEGFs) A and B with diabetic retinopathy severity and diabetic macular edema. Correlation between growth factors and anatomical parameters

Joana Mesquita; João Paulo Castro-de-Sousa; Paulo Tavares-Ratado; Cândida Tomaz

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):2949. doi:

ARVO Annual Meeting Abstract June 2020

Real-life long-term outcomes for patients treated with the 0.19 mg fluocinolone acetonide (FAc; ILUVIEN) intravitreal implant for DME: Three-year follow-up from the RegIstry Safety Study (IRISS) .

Ramin Khoramnia; Frank H J Koch; Usha Chakravarthy; Simon R Taylor; Joao Paulo Castro de Sousa; Clare Bailey

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):4862. doi:

ARVO Annual Meeting Abstract July 2019

Thrombophilic risk factors for retinal vein occlusion

Maria João Vieira; António Campos; Mónica Santos; Joana Pereira; Henrique Arruda; João Sousa

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):1713. doi:

ARVO Annual Meeting Abstract July 2019

RETINAL THICKNESS RESULTS PRIOR AND FOLLOWING TREATMENT WITH 0.19 MG FLUOCINOLONE ACETONIDE INTRAVITREAL IMPLANT FOR DIABETIC MACULAR EDEMA

Angela M Carneiro; Angelina Meireles; João Sousa; Carla Teixeira

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2605. doi:

ARVO Annual Meeting Abstract July 2019

Real-world outcomes from the 3-year European ILUVIEN (0.19 mg fluocinolone acetonide implant) RegIstry Safety Study (IRISS)

Frank HJ Koch; Usha Chakravarthy; Ramin Khoramnia; Simon Taylor; Clare Bailey; João Sousa

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2622. doi:

ARVO Annual Meeting Abstract July 2019

Earlier intervention is associated with improved visual outcomes in patients with persistent or recurrent diabetic edema - Clinical insights from the ILUVIEN (fluocinolone acetonide) Registry Safety Study (IRISS)

Panos Vouzounis; Simon Taylor; Usha Chakravarthy; Clare Bailey; Frank HJ Koch; João Sousa

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2630. doi:

ARVO Annual Meeting Abstract July 2019

LASER rescue in macular telangiectasia (MacTel)

Henrique Aragão Arruda; António Campos; Maria João Vieira; Joana Pereira; Mónica Santos; João Sousa

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2563. doi:

ARVO Annual Meeting Abstract July 2018

Quantitative research of VEGF-A, VEGF-B and PIGF in vitreous and serum in angiogenic ocular disorders

Joana Mesquita; João Paulo Castro de Sousa; Sara Vaz-Pereira; Arminda Neves; Luís Passarinha; Cândida Tomaz

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):3085. doi:

ARVO Annual Meeting Abstract June 2017

REAL-LIFE EFFICACY WITH ILUVIEN® (FLUOCINOLONE ACETONIDE [FAC]) IN DIABETIC MACULAR EDEMA (DME) PATIENTS IN 4 PORTUGUESE OPTHALMOLOGY UNITS

Angelina Meireles; Bernardete Pessoa; João Coelho; Carla Teixeira; Manuel Alberto Falcão; Rita Gonçalves; Marta Ines Silva; João Paulo Castro e Sousa

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):958. doi:

ARVO Annual Meeting Abstract June 2017

Choroidal thickness at 6 months and 1 year in eyes with DME treated with focal/grid LASER

Pedro Alfaiate; António Campos; Sónia Campos; Joana Pereira; Monica Santos; João Paulo Castro e Sousa

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):949. doi:

ARVO Annual Meeting Abstract June 2017

Quantitative analysis and correlation of VEGF-A and VEGF-B in serum and vitreous humor of patients with proliferative vs non-proliferative ocular disease

Joana Mesquita; João Paulo Castro e Sousa; Sara Vaz-Pereira; Arminda Neves; Luís Passarinha; Cândida Tomaz

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):604. doi:

ARVO Annual Meeting Abstract June 2017

Switching corticosteroids therapy for diabetic macular edema

Carlos Marques-Neves; João Paulo Castro e Sousa; David Martins; António Sampaio; Paulo Kaku

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):100. doi:

ARVO Annual Meeting Abstract June 2017

Safety and efficacy of fluocinolone acetonide intravitreal implant (Iluvien®) in patients with chronic diabetic macular edema in a real-life setting

Monica Santos; António Campos; Arminda Neves; Pedro Alfaiate; Joana Pereira; João Paulo Castro e Sousa

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):5032. doi:

ARVO Annual Meeting Abstract September 2016

Correlation between concentration of vitreous angiogenic cytokines (VEGF-B and PIGF) with central retinal thickness and macular volume in diabetic retinopathy patients

Joana Mesquita; João Paulo Castro Sousa; Sara Vaz-Pereira; Arminda Neves; Paulo Tavares-Ratado; Luís Passarinha; Cândida Tomaz

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):1758. doi:

ARVO Annual Meeting Abstract June 2015

Comparison of serum and vitreous PIGF in diabetic retinopathy patients and non-diabetic patients

Joana Mesquita; João Paulo Castro Sousa; Paulo Tavares-Ratado; Sara Vaz-Pereira; Arminda Neves; Ana S. Rocha; Fátima Santos; Luís Passarinha; Candida Tomaz

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):5179. doi:

ARVO Annual Meeting Abstract April 2014

Quantification and comparison of VEGF-B in the vitreous of patients with diabetic ocular disease and a control group of patients with non-diabetic ocular disease

Joana Mesquita; João Paulo Castro Sousa; Ana S Rocha; Fatima Santos; Joao Monteiro; Luís Passarinha; Cândida Tomaz

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):399. doi:

Advertisement